Latest News on Pfizer
Showing of 0 - 10 from 41 results
Pfizer - Total results - 41
Oct 24, 2014
Pfizer's $11 bn buyback plan deflates hopes of a new bid for AstraZeneca: US drugmaker Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca.
Sep 13, 2014
Relief for Ranbaxy as US court dismisses Lipitor antitrust case against co, PfizerRetailers and distribution companies claim that the settlement amounted to Pfizer paying Ranbaxy to stay out of the Lipitor market
Dec 29, 2013
Pharma sector registers single digit growth in 2013; regulators increase scrutinyThe Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers.
Dec 18, 2013
Pfizer, Teva reach deal to allow generic ViagraPfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.
Nov 24, 2013
Pfizer, Wyeth merge in India to create 9th largest pharma companyPfizer Inc bought rival Wyeth in 2009, leaving their Indian units with separate stock market listings. After the merger of their Indian operations, now they will operate under a single brand, Pfizer.
Jul 29, 2013
Pfizer agrees to sell key vaccines cheaply to poor countriesThe program also aims to increase vaccine production capacity and encourage companies to develop vaccines for diseases common in the poorest countries.
Jul 29, 2013
IBM, Boeing, 22 others continue India-specific lobbying in USAccording to latest lobbying disclosure reports filed with the US Senate and the House of Representatives, Pfizer, IBM,
Boeing, Dow Chemicals, Yum Brands and Colgate Palmolive are among the major companies that lobbied with the US lawmakers in the second quarter on issues related to India.
Jun 13, 2013
Teva, Sun Pharma to pay $2.15 bn to settle Pfizer patent suit for acid-reflux drugThis is the first instance of generic drugmakers paying damages for marketing a copy of an existing drug for which patents have yet to expire - known as an 'at-risk' launch.
Mar 14, 2013
India undermining intellectual property: Pfizer tells US lawmakersMonths after its patent for a cancer medication was revoked by India, American firm Pfizer has told US lawmakers that the country is undermining intellectual property by misuse of its compulsory licence provisions.
Jul 03, 2012
GlaxoSmithKline guilty in US drug fraud case, to pay $3 bnBritish drugmaker GlaxoSmithKline will pay $3 billion in fines - the largest health care fraud settlement in U.S. history - for criminal and civil violations involving 10 drugs that are taken by millions of people.